FDA slaps regs on fecal transplants. Increased steps for C. diff treatment draw mixed reactions from providers.
Maureen
M
McKinney
D001688:Biological Products / Q000592:standards*; D016360:Clostridioides difficile; D003015:Clostridium Infections / Q000382:microbiology / Q000628:therapy*; D005243:Feces / Q000382:microbiology*; D006801:Humans; D017387:Investigational New Drug Application; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards*
D001688:Biological Products